JP2020512287A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512287A5
JP2020512287A5 JP2019531167A JP2019531167A JP2020512287A5 JP 2020512287 A5 JP2020512287 A5 JP 2020512287A5 JP 2019531167 A JP2019531167 A JP 2019531167A JP 2019531167 A JP2019531167 A JP 2019531167A JP 2020512287 A5 JP2020512287 A5 JP 2020512287A5
Authority
JP
Japan
Prior art keywords
peptide
polymer
molecules
xten
elp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2019531167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020512287A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/082535 external-priority patent/WO2018108971A2/en
Publication of JP2020512287A publication Critical patent/JP2020512287A/ja
Priority to JP2024186110A priority Critical patent/JP2025013922A/ja
Publication of JP2020512287A5 publication Critical patent/JP2020512287A5/ja
Ceased legal-status Critical Current

Links

JP2019531167A 2016-12-13 2017-12-13 肺の炎症性疾患を処置するための方法 Ceased JP2020512287A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024186110A JP2025013922A (ja) 2016-12-13 2024-10-22 肺の炎症性疾患を処置するための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201670991 2016-12-13
DKPA201670991 2016-12-13
PCT/EP2017/082535 WO2018108971A2 (en) 2016-12-13 2017-12-13 Methods for treating inflammatory conditions of the lungs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024186110A Division JP2025013922A (ja) 2016-12-13 2024-10-22 肺の炎症性疾患を処置するための方法

Publications (2)

Publication Number Publication Date
JP2020512287A JP2020512287A (ja) 2020-04-23
JP2020512287A5 true JP2020512287A5 (cg-RX-API-DMAC7.html) 2024-11-01

Family

ID=61024712

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019531167A Ceased JP2020512287A (ja) 2016-12-13 2017-12-13 肺の炎症性疾患を処置するための方法
JP2024186110A Withdrawn JP2025013922A (ja) 2016-12-13 2024-10-22 肺の炎症性疾患を処置するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024186110A Withdrawn JP2025013922A (ja) 2016-12-13 2024-10-22 肺の炎症性疾患を処置するための方法

Country Status (13)

Country Link
US (2) US11413328B2 (cg-RX-API-DMAC7.html)
EP (1) EP3554532B1 (cg-RX-API-DMAC7.html)
JP (2) JP2020512287A (cg-RX-API-DMAC7.html)
KR (1) KR20190108106A (cg-RX-API-DMAC7.html)
CN (1) CN110290799A (cg-RX-API-DMAC7.html)
AU (1) AU2017376400A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019011844A2 (cg-RX-API-DMAC7.html)
CA (1) CA3045079A1 (cg-RX-API-DMAC7.html)
ES (1) ES2994381T3 (cg-RX-API-DMAC7.html)
MX (1) MX2019006848A (cg-RX-API-DMAC7.html)
RU (1) RU2019120956A (cg-RX-API-DMAC7.html)
SG (1) SG10202012106WA (cg-RX-API-DMAC7.html)
WO (1) WO2018108971A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200095472A (ko) * 2017-11-10 2020-08-10 디펜신 테라퓨틱스 에이피에스 조산아에서의 점막 방어 및 장/폐 기능의 성숙화
CN108815199B (zh) * 2018-08-03 2021-10-01 南华大学 鼠衣原体在制备抗溃疡性结肠炎药物中的应用
US11331269B2 (en) * 2018-09-06 2022-05-17 Massachusetts Institute Of Technology Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
KR102742007B1 (ko) 2018-10-09 2024-12-12 유니버시티 오브 서던 캘리포니아 양이온성 마크로사이클릭 펩티드의 전신 전달성, 내약성, 및 효능을 향상시키기 위한 조성물 및 방법(compositions and methods for enhancing systemic deliverability, tolerability, and efficacy of cationic macrocyclic peptides)
JP7479381B2 (ja) * 2019-01-07 2024-05-08 アエスクルス バイオ エーピーエス 治療または予防に使用するためのディフェンシン断片
WO2020182970A1 (en) * 2019-03-14 2020-09-17 Om Pharma Sa Process for making stable bacterial extracts and their use as pharmaceuticals
US12472231B2 (en) 2020-03-18 2025-11-18 The University Of Hong Kong Compositions of anti-viral peptides and methods of use thereof
CN113262297A (zh) * 2020-11-02 2021-08-17 中南大学湘雅二医院 一种基于巴氏菌的治疗性肺癌疫苗及其配置方法和应用
CN113521047B (zh) * 2021-08-23 2022-10-04 新疆医科大学第四附属医院 丁酸盐在制备慢性阻塞性肺疾病药物中的应用
EP4457237A4 (en) * 2021-12-27 2025-11-12 Versitech Ltd ANTIVIRAL PEPTIDES AND THEIR METHODS OF USE
CN121360148B (zh) * 2025-12-18 2026-06-30 白山市林源春生态科技股份有限公司 一种经特定发酵获得的太岁分子生态液提取物及其制备方法和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
CA2841097A1 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
US7511015B2 (en) * 2002-02-19 2009-03-31 The United States Of America As Represented By The Department Of Health And Human Services Modified defensins and their use
US20040091498A1 (en) 2002-05-31 2004-05-13 Aaron Diamond Aids Research Center Defensins: use as antiviral agents
GB0521139D0 (en) * 2005-10-18 2005-11-23 Univ Sheffield Therapeutic agent
US7528107B2 (en) 2005-11-30 2009-05-05 Auburn University Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins
WO2008115390A2 (en) 2007-03-16 2008-09-25 The Hamner Institutes For Health Sciences Methods of using defensins to treat diabetes
LT2237799T (lt) 2008-02-01 2019-07-25 Ascendis Pharma A/S Provaistas, apimantis besiskaidantį linkerį
CN102159233A (zh) 2008-07-18 2011-08-17 诺维信阿德宁生物技术公司 使用哺乳动物β防御素的炎性肠病的治疗
MX2011000569A (es) * 2008-07-18 2011-02-23 Novozymes Adenium Biotech As Tratamiento de enfermedades inflamatorias con beta-defensinas de mamifero.
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
US8828380B2 (en) * 2009-09-10 2014-09-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for the treatment of pulmonary disease and method of producing proteins of use therein
US8410049B2 (en) 2009-10-28 2013-04-02 Cebix Methods and kits for preventing hypoglycemia
KR101320472B1 (ko) * 2010-06-16 2013-10-23 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
WO2012064601A1 (en) * 2010-11-08 2012-05-18 Pulmatrix, Inc. Methods of treating and preventing rhinovirus infection
JP6219277B2 (ja) 2011-07-08 2017-10-25 ディフェンシン セラピューティクス アンパルトセルスカブDefensin Therapeutics Aps 炎症性腸疾患の経口治療
WO2013026794A1 (en) * 2011-08-19 2013-02-28 Novozymes Novel immunomodulatory peptide
US9464124B2 (en) * 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2928910B1 (en) * 2012-12-06 2019-09-04 PIN Pharma, Inc. Treatment of inflammation, autoimmune, and neurodegenerative disorders with immunosuppressive tat derivative polypeptides
KR20200095472A (ko) * 2017-11-10 2020-08-10 디펜신 테라퓨틱스 에이피에스 조산아에서의 점막 방어 및 장/폐 기능의 성숙화

Similar Documents

Publication Publication Date Title
FI3368555T3 (fi) Kaksitoimisia proteiineja ja niitä sisältävä farmaseuttinen koostumus
JP2016519569A5 (cg-RX-API-DMAC7.html)
JP2012505902A5 (cg-RX-API-DMAC7.html)
IL308831A (en) T cell receptors
JP2017538395A5 (cg-RX-API-DMAC7.html)
JP2018512856A5 (cg-RX-API-DMAC7.html)
JP2021511826A5 (cg-RX-API-DMAC7.html)
JP2011502479A5 (cg-RX-API-DMAC7.html)
HRP20200503T1 (hr) Fuzijski proteini
JP2017528419A5 (cg-RX-API-DMAC7.html)
JP2011518179A5 (cg-RX-API-DMAC7.html)
JP2016527314A5 (cg-RX-API-DMAC7.html)
JP2013537416A5 (cg-RX-API-DMAC7.html)
JP2013504318A5 (cg-RX-API-DMAC7.html)
FI2970398T3 (fi) Rsv f -prefuusioproteiineja ja niiden käyttö
JP2015500811A5 (cg-RX-API-DMAC7.html)
TW200942255A (en) Acylated GLP-1 compounds
AR064555A1 (es) Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo
JP2016531110A5 (cg-RX-API-DMAC7.html)
JP2013513377A5 (cg-RX-API-DMAC7.html)
JP2020518249A5 (cg-RX-API-DMAC7.html)
WO2017114240A1 (zh) 一种合成Etelcalcetide的方法
JP2016527248A5 (cg-RX-API-DMAC7.html)
AU2016214439B2 (en) Use of HLA-B27 homodimers for cancer treatment
JP2016532681A5 (cg-RX-API-DMAC7.html)